Developer docs
API playgroundTry for free, no card

Search company profiles

SigmaStim

Full company profile

uuid003cdlo

Namestring
SigmaStim
Legal namestring
SigmaStim
Websiteurl
sigmastim.com
Company typeenum
Private
Founded yearint
1980
Descriptiontext

SigmaStim, headquartered in the Portland, Oregon area (Tualatin), is a privately held medical device manufacturer specializing in electroconvulsive therapy (ECT) systems. The company produces the Σigma ECT Device, a controlled-electrical-pulse system used under anesthesia to induce therapeutic seizures for the treatment of severe psychiatric conditions including treatment-resistant major depression, bipolar disorder, psychotic illnesses such as schizophrenia, catatonia, and epilepsy. The device integrates physiological monitoring capabilities (EEG, ECG, EMG, blood pressure, and O2 saturation), built-in electrode placement configurations, and printable biomedical and error log reports. The product line is complemented by a Σigma Starter Kit for new customers, optional accessories, Σigma EMR Software for clinical documentation, and clinician instructional materials.

The company sells exclusively to licensed healthcare providers and hospitals in the US and Canada through a direct enterprise sales motion (phone, email, same-business-day response), while international customers are served through a network of local distributors. Revenue streams consist of one-time device and software license sales, hardware accessories, and training and education revenue through the International Course on Electroconvulsive Therapy, which features expert faculty including Dr. Harold Sackeim, Dr. Colleen Loo, and Dr. William Vaughn McCall.

SigmaStim operates through two LLC entities — SigmaStim Domestic LLC for US sales and SigmaStim International LLC for international sales — and is owned by Balance Point LLC, with no disclosed external investors or venture funding. The company maintains FDA clearance for its device and its Patients and Families Information Booklet, and operates with 11–50 employees. There is no evidence of recent M&A, leadership changes, or material strategic repositioning in the available source material.

Short descriptiontext

SigmaStim is a privately held Oregon-based medical device manufacturer that sells the FDA-cleared Σigma electroconvulsive therapy (ECT) system, EMR software, accessories, and clinician training exclusively to licensed healthcare providers and hospitals in the US, Canada, and internationally via distributors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTualatin, United States
HQ citystring
Tualatin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
electroconvulsive therapy devices, ECT medical devices, psychiatric treatment equipment, medical device manufacturing, EMR software psychiatry
Industry3 codes
PRIMARYHLAHAFAD
Electrophysiology Mapping & Ablation Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAAAL
EHR Implementation, Optimization, Training & Managed Services
Healthcare & Life Sciences/Digital Health & Health IT/Electronic Health Records (EHR/EMR) & Clinical Documentation
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Electroconvulsive Therapy Devices
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1ECT Device Sales
TypeOne Time License
Description

Sale of Σigma ECT devices to licensed healthcare providers and hospitals. This is the primary revenue stream for the company.

sigmastim.com
2EMR Software
TypeOne Time License
Description

Sale of SigmaStim EMR software for ECT documentation and clinical records management.

sigmastim.com
3Accessories and Consumables
TypeHardware Sales
Description

Sale of Σigma ECT accessories and optional add-ons for the device system.

sigmastim.com
4Training and Education
TypeProfessional Services
Description

The company offers the International Course on Electroconvulsive Therapy with individual lecture purchases and full course bundles. Includes PDF presentation slides and exclusive Q&A recordings. Faculty includes Dr. Harold Sackeim, Dr. Colleen Loo, and Dr. William Vaughn McCall.

sigmastim.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Σigma ECT Device
Description

The primary electroconvulsive therapy device product line sold by SigmaStim.

sigmastim.com
+2 more records
Core offering1 text field

SigmaStim manufactures and sells the Σigma (Sigma) Electroconvulsive Therapy (ECT) device system — a FDA-cleared medical device that delivers controlled electrical pulses under anesthesia to treat severe psychiatric conditions such as treatment-resistant major depression, bipolar disorder, schizophrenia, catatonia, and epilepsy. The integrated system includes proprietary electrical dosing control, configurable electrode placement, multi-parameter physiological monitoring (EEG, ECG, EMG, BP, O2), and Σigma EMR software for ECT-specific clinical documentation. The company also supplies accessories, a starter kit, clinician instructional materials, and paid training through the International Course on ECT.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • High remission rate for major depression
+1 more record
Product overview1 text field

SigmaStim offers the ΣIGMA line of electroconvulsive therapy (ECT) medical devices and related products. The core product is the ΣIGMA ECT DEVICE, which is complemented by a STARTER KIT for new purchases, optional ACCESSORIES for ongoing clinical use, EMR SOFTWARE for electronic medical records integration, and INSTRUCTIONAL MATERIALS for clinician training. The company sells exclusively to licensed health providers and hospitals and does not provide direct services to patients.

Product and service5 records
1ΣIGMA ECT Device
CategoryECT medical device (hardware)
Description

The primary electroconvulsive therapy (ECT) device manufactured by SigmaStim, used by licensed healthcare providers and hospitals to deliver controlled electrical pulses under anesthesia to induce therapeutic seizures for treating severe psychiatric disorders including major depression, bipolar disorder, and psychotic illnesses such as schizophrenia. Features proprietary electrical dosing control, configurable electrode placement, and built-in physiological monitoring covering EEG, ECG, EMG, blood pressure, and oxygen saturation, plus printable Biomedical Reports and Error Logs.

2ΣIGMA Starter Kit
CategoryECT device accessory bundle
Description

A bundled starting package offered to clinicians and hospitals purchasing the Σigma ECT device, providing essential accessories and materials needed to begin using the device in a clinical ECT program.

3ΣIGMA Accessories
CategoryECT device accessories / consumables
Description

Optional accessories, replacement parts, and supplementary consumable components sold separately for ongoing clinical use of the Σigma ECT device.

4ΣIGMA EMR Software
CategoryEMR / clinical software
Description

Electronic Medical Records software designed to integrate with the Σigma ECT device, providing ECT-specific clinical documentation, treatment-course records, and workflow management for clinicians and hospitals administering ECT.

5International Course on Electroconvulsive Therapy
CategoryClinical training / professional services
Description

Paid online training course on electroconvulsive therapy for clinicians, featuring expert faculty including Dr. Harold Sackeim, Dr. Colleen Loo, and Dr. William Vaughn McCall, sold via individual lecture purchases and full course bundles.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Medtronic's Neuromodulation division offers DBS and other stimulation platforms for neurological and psychiatric conditions, providing a broad incumbent competitor with significantly greater R&D and commercial scale than SigmaStim.

TypeEmerging player
Description

Neuronetics commercializes NeuroStar TMS systems for treatment-resistant depression, an alternative neuromodulation modality competing for the same clinical indications and psychiatrist prescribing decisions as ECT.

TypeEmerging player
Description

NeuroPace develops the RNS System, a responsive neurostimulation device for epilepsy. While focused on seizure disorders rather than depression, it represents an adjacent implantable neurotechnology competitor that shares neuroscience research overlap with ECT.

TypeBroad incumbent
Description

LivaNova (formerly Cyberonics) markets vagus nerve stimulation (VNS) therapy for treatment-resistant depression, overlapping with ECT in indication and competing for the same specialist prescriber audience as part of a broader neuromodulation portfolio.

TypeEmerging player
Description

Brainsway develops deep TMS systems for depression and other psychiatric and neurological conditions, positioning itself as a less invasive alternative to ECT for treatment-resistant patients.

TypeDirect peer
Description

Somatics manufactures the Thymatron line of ECT devices, the other principal ECT equipment brand used in U.S. psychiatric hospitals. It is a direct competitor to SigmaStim on device specifications, dosing algorithms, and clinical training.

7Magstim
TypeEmerging player
Description

Magstim supplies transcranial magnetic stimulation systems and research-grade neurostimulation equipment used in both clinical psychiatry and neuroscience research, competing indirectly with ECT for treatment-resistant depression cases.

TypeEmerging player
Description

Soterix Medical develops transcranial direct current stimulation (tDCS) and other non-invasive brain stimulation systems, providing another less invasive alternative to ECT that competes for psychiatric and neurological research and clinical adoption.

TypeDirect peer
Description

MECTA is one of the longest-established U.S. manufacturers of ECT devices and is closely associated with the SigmaStim product lineage referenced in the company's data. It competes head-to-head in the same narrow ECT device category with similar clinical positioning.

TypeBroad incumbent
Description

Abbott operates a broad neuromodulation business (including deep brain stimulation and spinal cord stimulation) that addresses psychiatric and neurological disorders, competing for hospital neuromoduation budgets that may otherwise be allocated to ECT.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SigmaStim

Electroconvulsive Therapy Devicessigmastim.com

SigmaStim is a privately held Oregon-based medical device manufacturer that sells the FDA-cleared Σigma electroconvulsive therapy (ECT) system, EMR software, accessories, and clinician training exclusively to licensed healthcare providers and hospitals in the US, Canada, and internationally via distributors.

What SigmaStim does

SigmaStim, headquartered in the Portland, Oregon area (Tualatin), is a privately held medical device manufacturer specializing in electroconvulsive therapy (ECT) systems. The company produces the Σigma ECT Device, a controlled-electrical-pulse system used under anesthesia to induce therapeutic seizures for the treatment of severe psychiatric conditions including treatment-resistant major depression, bipolar disorder, psychotic illnesses such as schizophrenia, catatonia, and epilepsy. The device integrates physiological monitoring capabilities (EEG, ECG, EMG, blood pressure, and O2 saturation), built-in electrode placement configurations, and printable biomedical and error log reports. The product line is complemented by a Σigma Starter Kit for new customers, optional accessories, Σigma EMR Software for clinical documentation, and clinician instructional materials.

The company sells exclusively to licensed healthcare providers and hospitals in the US and Canada through a direct enterprise sales motion (phone, email, same-business-day response), while international customers are served through a network of local distributors. Revenue streams consist of one-time device and software license sales, hardware accessories, and training and education revenue through the International Course on Electroconvulsive Therapy, which features expert faculty including Dr. Harold Sackeim, Dr. Colleen Loo, and Dr. William Vaughn McCall.

SigmaStim operates through two LLC entities — SigmaStim Domestic LLC for US sales and SigmaStim International LLC for international sales — and is owned by Balance Point LLC, with no disclosed external investors or venture funding. The company maintains FDA clearance for its device and its Patients and Families Information Booklet, and operates with 11–50 employees. There is no evidence of recent M&A, leadership changes, or material strategic repositioning in the available source material.

SigmaStim firmographics

Firmographics
Name
SigmaStim
Legal name
SigmaStim
Website
https://sigmastim.com
Company type
Private
Founded year
1980
Operating status
Operating
Headcount range
11–50 employees
Short description
SigmaStim is a privately held Oregon-based medical device manufacturer that sells the FDA-cleared Σigma electroconvulsive therapy (ECT) system, EMR software, accessories, and clinician training exclusively to licensed healthcare providers and hospitals in the US, Canada, and internationally via distributors.
Ownership category
akta.pro rank

SigmaStim industry classification

Industry
Product category
Electroconvulsive Therapy Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAFAD
Electrophysiology Mapping & Ablation Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAAAL
EHR Implementation, Optimization, Training & Managed Services
Healthcare & Life Sciences/Digital Health & Health IT/Electronic Health Records (EHR/EMR) & Clinical Documentation

Keywords

  • Electroconvulsive therapy devices
  • ECT medical devices
  • Psychiatric treatment equipment
  • Medical device manufacturing
  • EMR software psychiatry

Where SigmaStim is headquartered

Location

Headquarters

HQ city
Tualatin
HQ country
United States
HQ region
North America

Offices1 record

Markets served

SigmaStim business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. ECT Device Sales: Sale of Σigma ECT devices to licensed healthcare providers and hospitals. This is the primary revenue stream for the company.
  2. EMR Software: Sale of SigmaStim EMR software for ECT documentation and clinical records management.
  3. Accessories and Consumables: Sale of Σigma ECT accessories and optional add-ons for the device system.
  4. Training and Education: The company offers the International Course on Electroconvulsive Therapy with individual lecture purchases and full course bundles. Includes PDF presentation slides and exclusive Q&A recordings. Faculty includes Dr. Harold Sackeim, Dr. Colleen Loo, and Dr. William Vaughn McCall.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

SigmaStim product offering

Product offering

Core offering

SigmaStim manufactures and sells the Σigma (Sigma) Electroconvulsive Therapy (ECT) device system — a FDA-cleared medical device that delivers controlled electrical pulses under anesthesia to treat severe psychiatric conditions such as treatment-resistant major depression, bipolar disorder, schizophrenia, catatonia, and epilepsy. The integrated system includes proprietary electrical dosing control, configurable electrode placement, multi-parameter physiological monitoring (EEG, ECG, EMG, BP, O2), and Σigma EMR software for ECT-specific clinical documentation. The company also supplies accessories, a starter kit, clinician instructional materials, and paid training through the International Course on ECT.

Product overview

SigmaStim offers the ΣIGMA line of electroconvulsive therapy (ECT) medical devices and related products. The core product is the ΣIGMA ECT DEVICE, which is complemented by a STARTER KIT for new purchases, optional ACCESSORIES for ongoing clinical use, EMR SOFTWARE for electronic medical records integration, and INSTRUCTIONAL MATERIALS for clinician training. The company sells exclusively to licensed health providers and hospitals and does not provide direct services to patients.

Differentiator

Problem solved

Functional benefit

Brands

  • Σigma ECT Device: The primary electroconvulsive therapy device product line sold by SigmaStim.
  • Σigma EMR Software
  • Σigma Starter Kit

Products and services

  • ΣIGMA ECT Device The primary electroconvulsive therapy (ECT) device manufactured by SigmaStim, used by licensed healthcare providers and hospitals to deliver controlled electrical pulses under anesthesia to induce therapeutic seizures for treating severe psychiatric disorders including major depression, bipolar disorder, and psychotic illnesses such as schizophrenia. Features proprietary electrical dosing control, configurable electrode placement, and built-in physiological monitoring covering EEG, ECG, EMG, blood pressure, and oxygen saturation, plus printable Biomedical Reports and Error Logs.
  • ΣIGMA Starter Kit A bundled starting package offered to clinicians and hospitals purchasing the Σigma ECT device, providing essential accessories and materials needed to begin using the device in a clinical ECT program.
  • ΣIGMA Accessories Optional accessories, replacement parts, and supplementary consumable components sold separately for ongoing clinical use of the Σigma ECT device.
  • ΣIGMA EMR Software Electronic Medical Records software designed to integrate with the Σigma ECT device, providing ECT-specific clinical documentation, treatment-course records, and workflow management for clinicians and hospitals administering ECT.
  • International Course on Electroconvulsive Therapy Paid online training course on electroconvulsive therapy for clinicians, featuring expert faculty including Dr. Harold Sackeim, Dr. Colleen Loo, and Dr. William Vaughn McCall, sold via individual lecture purchases and full course bundles.

Quantifiable outcome

  • High remission rate for major depression
  • +1 more outcomes

Companies that use SigmaStim

Customer profile

Segments1 record

Ideal customer profiles1 record

SigmaStim technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

SigmaStim partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

SigmaStim competitors and assessment

Company assessment

Broad incumbents

  • Medtronic: Medtronic's Neuromodulation division offers DBS and other stimulation platforms for neurological and psychiatric conditions, providing a broad incumbent competitor with significantly greater R&D and commercial scale than SigmaStim.
  • LivaNova: LivaNova (formerly Cyberonics) markets vagus nerve stimulation (VNS) therapy for treatment-resistant depression, overlapping with ECT in indication and competing for the same specialist prescriber audience as part of a broader neuromodulation portfolio.
  • Abbott: Abbott operates a broad neuromodulation business (including deep brain stimulation and spinal cord stimulation) that addresses psychiatric and neurological disorders, competing for hospital neuromoduation budgets that may otherwise be allocated to ECT.

Emerging players

  • Neuronetics: Neuronetics commercializes NeuroStar TMS systems for treatment-resistant depression, an alternative neuromodulation modality competing for the same clinical indications and psychiatrist prescribing decisions as ECT.
  • NeuroPace: NeuroPace develops the RNS System, a responsive neurostimulation device for epilepsy. While focused on seizure disorders rather than depression, it represents an adjacent implantable neurotechnology competitor that shares neuroscience research overlap with ECT.
  • Brainsway: Brainsway develops deep TMS systems for depression and other psychiatric and neurological conditions, positioning itself as a less invasive alternative to ECT for treatment-resistant patients.
  • Magstim: Magstim supplies transcranial magnetic stimulation systems and research-grade neurostimulation equipment used in both clinical psychiatry and neuroscience research, competing indirectly with ECT for treatment-resistant depression cases.
  • Soterix Medical: Soterix Medical develops transcranial direct current stimulation (tDCS) and other non-invasive brain stimulation systems, providing another less invasive alternative to ECT that competes for psychiatric and neurological research and clinical adoption.

Direct peers

  • Somatics LLC: Somatics manufactures the Thymatron line of ECT devices, the other principal ECT equipment brand used in U.S. psychiatric hospitals. It is a direct competitor to SigmaStim on device specifications, dosing algorithms, and clinical training.
  • MECTA Corporation: MECTA is one of the longest-established U.S. manufacturers of ECT devices and is closely associated with the SigmaStim product lineage referenced in the company's data. It competes head-to-head in the same narrow ECT device category with similar clinical positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

SigmaStim financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SigmaStim leadership team

Management profile

Number of profiles

SigmaStim funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SigmaStim M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SigmaStim

What does SigmaStim do?

SigmaStim manufactures and sells the Σigma (Sigma) Electroconvulsive Therapy (ECT) device system — a FDA-cleared medical device that delivers controlled electrical pulses under anesthesia to treat severe psychiatric conditions such as treatment-resistant major depression, bipolar disorder, schizophrenia, catatonia, and epilepsy. The integrated system includes proprietary electrical dosing control, configurable electrode placement, multi-parameter physiological monitoring (EEG, ECG, EMG, BP, O2), and Σigma EMR software for ECT-specific clinical documentation. The company also supplies accessories, a starter kit, clinician instructional materials, and paid training through the International Course on ECT.

Is SigmaStim a public or private company?

SigmaStim is a private company. It is classified as corporate owned and is currently operating.

When was SigmaStim founded?

SigmaStim was founded in 1980. It employs 11 to 50 people.

Where is SigmaStim based?

SigmaStim is headquartered in Tualatin, United States, in the North America region.

How does SigmaStim make money?

Four revenue lines are on record. ECT Device Sales are the primary driver. The others are EMR Software, accessories and Consumables and training and Education.

Who are SigmaStim's main competitors?

Broad incumbents on record are Medtronic, LivaNova and Abbott. Emerging players are Neuronetics, NeuroPace, Brainsway, Magstim and Soterix Medical. Direct peers are Somatics LLC and MECTA Corporation.

Does SigmaStim have an API?

No public API is recorded for SigmaStim.

What industry is SigmaStim in?

SigmaStim's product category is Electroconvulsive Therapy Devices. Its primary akta.pro industry code is HLAHAFAD, Electrophysiology Mapping & Ablation Systems, with a secondary code of HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales